Trial
NCT00598091
A Phase I/Expansion Study of Dasatinib
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
Bristol-Myers Squibb
Condition
Refractory Solid Tumors
Intervention
gemcitabine
Why stopped
Low accrual, unable to meet endpoint in timely manner
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-07